These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19561136)

  • 1. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.
    Kolibianakis EM; Venetis CA; Diedrich K; Tarlatzis BC; Griesinger G
    Hum Reprod Update; 2009; 15(6):613-22. PubMed ID: 19561136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.
    Zhang Y; Zhang C; Shu J; Guo J; Chang HM; Leung PCK; Sheng JZ; Huang H
    Hum Reprod Update; 2020 Feb; 26(2):247-263. PubMed ID: 32045470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.
    Lin G; Zhong X; Li S; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1215755. PubMed ID: 38027219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis.
    Kolibianakis EM; Collins J; Tarlatzis BC; Devroey P; Diedrich K; Griesinger G
    Hum Reprod Update; 2006; 12(6):651-71. PubMed ID: 16920869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders.
    Zhu J; Wang Y; Chen L; Liu P; Li R; Qiao J
    Front Endocrinol (Lausanne); 2020; 11():1. PubMed ID: 32038495
    [No Abstract]   [Full Text] [Related]  

  • 10. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
    Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
    Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
    González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
    Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL; Wang L; Lv F; Huang XM; Wang LP; Pan Y; Zhang XM
    Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis.
    Yu X; Ruan J; He LP; Hu W; Xu Q; Tang J; Jiang J; Han J; Peng YF
    Int J Clin Exp Med; 2015; 8(4):4954-67. PubMed ID: 26131068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone plus gonadotropins on controlled ovarian stimulation in infertile women of advanced age, poor responders, and previous in vitro fertilization failure patients.
    Ho YK; Lee TH; Lee CI; Cheng EH; Huang CC; Huang LS; Lee MS
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):806-810. PubMed ID: 29241924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis.
    Kolibianakis EM; Kalogeropoulou L; Griesinger G; Papanikolaou EG; Papadimas J; Bontis J; Tarlatzis BC
    Hum Reprod Update; 2007; 13(5):445-52. PubMed ID: 17586849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
    Kyrou D; Kolibianakis EM; Venetis CA; Papanikolaou EG; Bontis J; Tarlatzis BC
    Fertil Steril; 2009 Mar; 91(3):749-66. PubMed ID: 18639875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.